Legend: 
= Applied Session,
= Theme Session,
= Presenter, Sheraton Seattle Hotel & Towers = “S”
Washington State Convention & Trade Center = “CC”, Grand Hyatt Seattle = “H”
|
|
|
|
|
72
|
Sun, 8/6/06, 4:00 PM - 5:50 PM
|
CC-2A
|
|
Clinical Trial Design and Analysis - Contributed - Papers
|
Biopharmaceutical Section, Biometrics Section, WNAR, ENAR
|
|
Chair(s): Sheng Feng, Duke University
|
|
4:05 PM
|
Note on Randomization-Based Inferences for Randomized Clinical Trials —  Guohua Pan, Johnson & Johnson Pharmaceutical R&D; Yibin Wang, Novartis Pharmaceuticals Corporation
|
|
4:20 PM
|
Four Types of Sums of Squares and Estimates of Treatment Differences in Multicenter Clinical Trials — Daozhi Zhang, Daiichi Sankyo, Inc.
|
|
4:35 PM
|
Optimal Allocation of Units When Comparing k Treatments to Two Controls of Unequal Importance — Nairanjana Dasgupta, Washington State University
|
|
4:50 PM
|
A Method for Testing a Prespecified Subgroup in Clinical Trials — Yang Song, Johnson & Johnson Pharmaceutical R&D; George Chi, Johnson & Johnson Pharmaceutical R&D
|
|
5:05 PM
|
Some Issues in Fitting Clinical Count Data with Poisson Regression Model — Abdul Sankoh, sanofi-aventis
|
|
5:20 PM
|
Interval Estimation of Risk Ratio in the Simple Compliance Randomized Trial — Kung-Jong Lui, San Diego State University
|
|
5:35 PM
|
Floor Discussion
|
| |
